Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Most readers would already be aware that Privia Health Group's (NASDAQ:PRVA) stock increased significantly by 13% over the past three months. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. Particularly, we will be paying attention to Privia Health Group's ROE today.
大多數讀者都已經知道,Privia Health Group(納斯達克:PRVA)的股價在過去三個月中顯著增長了13%。由於大多數人知道,基本面通常引導長期市場價格走勢,所以我們決定今天查看公司的關鍵財務指標,以確定它們是否在最近的價格運動中發揮任何作用。特別是,我們今天將關注Privia Health Group的roe。
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. Simply put, it is used to assess the profitability of a company in relation to its equity capital.
股東權益回報率(ROE)是測試公司如何有效地增加其價值並管理投資者資金的指標。簡而言之,它用於評估公司相對於股本資本的盈利能力。
How Is ROE Calculated?
淨資產收益率怎麼計算?
The formula for ROE is:
roe的公式是:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
淨資產收益率 = 淨利潤(從持續經營中獲得)÷ 股東權益
So, based on the above formula, the ROE for Privia Health Group is:
所以,根據上述公式,Privia Health Group的ROE爲:
2.5% = US$16m ÷ US$644m (Based on the trailing twelve months to June 2024).
2.5%= US $ 1600萬 ÷ US $ 64400萬(截至2024年6月的過去十二個月)。
The 'return' is the profit over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.02.
「回報」是過去十二個月的利潤。這意味着,對於每1美元的股東投資,公司可以產生0.02美元的利潤。
Why Is ROE Important For Earnings Growth?
ROE爲什麼對淨利潤增長很重要?
We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming all else is equal, companies that have both a higher return on equity and higher profit retention are usually the ones that have a higher growth rate when compared to companies that don't have the same features.
我們已經確定ROE作爲評估公司未來收益的有效指標。現在我們需要評估公司爲未來增長所保留的利潤量,從而給我們一個關於公司增長潛力的想法。假設其他條件都相同,既具有較高ROE又具有較高利潤保留的公司通常是增長率更高的公司,相比之下沒有這些特點的公司會更低。
Privia Health Group's Earnings Growth And 2.5% ROE
Privia Health Group的盈利增長和2.5%的roe
It is quite clear that Privia Health Group's ROE is rather low. Not just that, even compared to the industry average of 12%, the company's ROE is entirely unremarkable. However, we we're pleasantly surprised to see that Privia Health Group grew its net income at a significant rate of 34% in the last five years. Therefore, there could be other reasons behind this growth. For example, it is possible that the company's management has made some good strategic decisions, or that the company has a low payout ratio.
很明顯,Privia Health Group的roe相當低。不僅如此,即使與12%的行業平均水平相比,該公司的roe也完全平凡。但是,我們驚喜地發現,過去五年中,Privia Health Group將其淨收入增長了34%。因此,這種增長可能還有其他原因。例如,公司的管理層可能已經做出了一些明智的戰略決策,或者公司的股息支付比率很低。
We then compared Privia Health Group's net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 7.1% in the same 5-year period.
然後,我們將Privia Health Group的淨收入增長率與行業進行了比較,很高興看到公司的增長率比同一5年期內增長率爲7.1%的整個行業更高。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240815/0-17dc98f6ee6138c1b91d977de59a3f23-0-740c69cc5e7675f1a0468d5459e7c6c4.png/big)
Earnings growth is an important metric to consider when valuing a stock. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. One good indicator of expected earnings growth is the P/E ratio which determines the price the market is willing to pay for a stock based on its earnings prospects. So, you may want to check if Privia Health Group is trading on a high P/E or a low P/E, relative to its industry.
盈利增長是考慮股票價值時需要考慮的重要指標。接下來,投資者需要確定的是,預期的盈利增長或缺乏盈利增長是否已經構建到股價中。這樣做,他們將了解股票是進入清澈的藍色水域還是等待泥濘的水域。預期盈利增長的一個很好的指標是市盈率,它根據公司的盈利前景決定市場願意爲一隻股票支付的價格。因此,您可能希望查看Privia Health Group相對於其行業是在高PE還是低PE交易。
Is Privia Health Group Using Its Retained Earnings Effectively?
Privia Health Group是否正在有效利用其留存收益?
Privia Health Group doesn't pay any regular dividends to its shareholders, meaning that the company has been reinvesting all of its profits into the business. This is likely what's driving the high earnings growth number discussed above.
Privia Health Group沒有向股東支付任何定期股息,這意味着該公司一直將其所有利潤再投資於業務中。這很可能是上述高盈利增長率的驅動因素。
Summary
總的來說,我們對偉明環保的表現非常滿意。具體而言,我們喜歡公司以高回報率再投資了其利潤的很大一部分。當然,這導致公司的收益大幅增長。但是,最新的行業分析師預測表明,該公司的收益預計將加速增長。
On the whole, we do feel that Privia Health Group has some positive attributes. Even in spite of the low rate of return, the company has posted impressive earnings growth as a result of reinvesting heavily into its business. We also studied the latest analyst forecasts and found that the company's earnings growth is expected be similar to its current growth rate. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.
總體而言,我們確實認爲Privia Health Group具有一些積極的特徵。儘管回報率低,但由於大規模再投資其業務,該公司發佈了令人矚目的盈利增長。我們還研究了最新的分析師預測,發現公司的盈利增長預計與其當前的增長率相似。要了解有關該公司未來盈利增長預測的更多信息,請查看此免費報告,了解分析師對該公司的預測。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。